In patients with persistent left superior vena cava undergoing cardiac device implantation, long-term outcomes are primarily determined by the underlying structural heart disease rather than the venous anomaly.
May reassure on device implantation in PLSVC; hypothesis-generating that outcomes depend on underlying disease, not anomaly.
BACKGROUND: Persistent left superior vena cava (LSVC) is a rare congenital venous anomaly that may be found at the time of cardiac device lead insertion. METHODS: In this case series, we present clinical and long-term data of five patients with LSVC who underwent pacemaker (PM) or cardioverter defibrillator (ICD) implantation during the period of 10 years. RESULTS: Left-sided venous approach was used for device implantation in 3 patients with standard PM indications, whereas a right-sided venous approach and an epicardial approach had to be used in 2 patients who needed an ICD and biventricular PM, respectively. In post implantation period of 44 ± 29 months, one patient died due to stroke, one underwent heart transplantation, and 3 had atrial fibrillation. CONCLUSION: The long-term outcome of patients with persistent LSVC and implanted cardiac devices is mostly influenced by the presence of underlying heart disease.
No takes yet. Share an insight, caveat, or question.
Petrac (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: